Femme et Homme
- | Pays :
- Japan
- | Organes : -
- | Spécialités : -
Extrait
The purpose of this study is to evaluate the safety and efficacy of MP-513 (Teneligliptin) in combination with Sulfonylurea in patients with type 2 Diabetes for 12 weeks administration and to evaluate the safety and efficacy of MP-513 in combination with Sulfonylurea with an extension treatment for up to 52 weeks.
Critère d'inclusion
- Type 2 diabetes mellitus